首页> 外文期刊>Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society >Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment
【24h】

Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment

机译:即使在进行肿瘤治疗之前,卵巢癌患者对卵巢过度刺激的反应也已减弱

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To evaluate the results of controlled ovarian stimulation before chemotherapy for oocyte vitrification to preserve fertility in women diagnosed with cancer and compare them with a historical control group. Design: A retrospective, multicenter, observational study performed between March 2007 and January 2011. Setting: University-affiliated infertility clinics. Patient(s): Of 272 patients affected by cancer in our Fertility Preservation Program, 223 women underwent a stimulated cycle for oocyte vitrification according to our protocols before cancer treatment. Their results were compared with a historical control group of 98 patients diagnosed with male factor infertility who were stimulated for a conventional IVF cycle. Intervention(s): Controlled ovarian stimulation and oocyte retrieval. Main Outcome Measure(s): Days of stimulation, total dose of gonadotropins, estrogen levels, and number of oocytes retrieved and vitrified. Result(s): No differences were found in days of stimulation, but significant differences in E 2 levels and the number of retrieved oocytes were measured, especially in the hormone-dependent cancer group. Conclusion(s): Patients with hormone-dependent cancer had a weaker response to controlled ovarian stimulation compared with patients with non-hormone-dependent cancer. Whether the oncological disease already affects the ovaries before chemo-/radiotherapy remains to be elucidated.
机译:目的:评估化疗前卵巢刺激对卵母细胞玻璃化以保持受孕女性的生育能力的结果,并将其与历史对照组进行比较。设计:一项回顾性,多中心,观察性研究,于2007年3月至2011年1月间进行。环境:大学附属的不育诊所。患者:在我们的“生育保护计划”中,有272名受癌症影响的患者中,有223名妇女在接受癌症治疗之前,按照我们的方案进行了卵母细胞玻璃化刺激周期。将他们的结果与一个历史对照组进行比较,该对照组是由98名诊断为男性因素不育的患者组成,他们接受了常规的IVF周期刺激。干预措施:受控的卵巢刺激和卵母细胞取出。主要观察指标:刺激天数,促性腺激素总剂量,雌激素水平以及取回和玻璃化的卵母细胞数量。结果:刺激天数未见差异,但测量到的E 2水平和回收的卵母细胞数量存在显着差异,尤其是激素依赖性癌症组。结论:与非激素依赖性癌症患者相比,激素依赖性癌症患者对受控卵巢刺激的反应较弱。在化学疗法/放射疗法之前,肿瘤疾病是否已经影响卵巢仍有待阐明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号